ULTIMA HORA

COVID 19 SOLICITUD AYUDA ESTUDIO EPIDEMIOLOGICO

Queridos amigos, familia, colegas

En este difícil momento del brote de COVID-19, sabemos que muchas personas están sufriendo emocional y mentalmente. Por ello, la Fundación Cerebro y Mente está llevando a cabo un estudio para determinar cómo este brote afecta a los síntomas de ansiedad y depresión en la población española (los infectados, los no infectados o los no probados). Un mes después de que se hayan levantado las restricciones de aislamiento, volveremos a evaluar estos síntomas, para ver si han mejorado. Les invitamos a ayudarnos con este importante estudio. Es importante que entendamos cómo la pandemia y el aislamiento social influyen en la salud mental. Queremos ver qué factores ayudan a las personas a sobrellevar mejor la situación y qué factores hacen que las personas sean más susceptibles de desarrollar ansiedad y síntomas depresivos. Esta información nos ayudará a desarrollar estrategias de tratamiento para después del COVID-19. También nos proporcionará pautas para la atención de la salud mental durante futuras pandemias. Por favor, envíen el enlace al mayor número de personas posible y mantengámonos unidos y ayudemos a mejorar la salud mental en España.

FORMULARIO

Gracias

Últimas Publicaciones

SALUD MENTAL EN LAS PERSONAS MAYORES

libro personas mayores

Una Guía Práctica

Versión Española

Mayo 2019

STRATEGIES FOR STUDYING BRAIN DISORDERS

Vol.9 Sistema Dopaminérgico y Trastornos Psiquiátricos

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

June 2013

ISBN: 978-1-4614-7263-6

Próximo curso

Madrid 11 y 12 de Noviembre de 2019

IX Curso Teórico-Práctico Intensivo de actualización en Terapia Electroconvulsiva

Más información

Último congreso

Fecha 20-21 Junio 2014

Relevance of Staging Psychotic disorders as a Paradigm-shift for understanding disease progression and stage-dependent treatment.

Más información

Publicaciones

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

June 2013

Editores: Tomás Palomo, Richard J. Beninger, Richard M. Kostrzewa

Editorial: Springer Science + Business Media, LLC, 233 Spring Street, New York, NY 10013, USA

ISBN: 978-1-4614-7263-6

Páginas: 433

Más información

Also found within the publication, are contributions presented at the meeting held in Mojácar in 2009.

Tabla de contenidos

Part I Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment

  • Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients
    Richard J. Beninger, Tyson W. Baker, Matthew M. Florczynski and Tomek J. Banasikowski
  • Staging in Neuropsychiatry: A Heuristic Model for Understanding, Prevention and Treatment
    Patrick D. McGorry
  • Brain Imaging in Early Stages of Psychosis: From the at Risk Mental State to First Episode
    Philip McGuire
  • Mechanisms of Illness Progression in the Recurrent Affective Disorders
    Robert M. Post
  • Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the Evidence
    Ralf Pukrop and Joachim Klosterkötter
  • Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment
    Thomas N. Chase
  • Staging Bipolar Disorder
    Eduard Vieta, M. Reinares and A.R. Rosa
  • Inflammatory Biomarkers and Depression
    Norbert Müller, Aye-Mu Myint and Markus J. Schwarz
  • Does Higher Potency of Cannabis Mean Higher Risk for Psychosis?
    Marta Di Forti, Alessandra Paparelli, Paola Casadio and Robin M. Murray
  • 5-HT2A Polymorphisms and Negative Symptoms Response to Antipsychotic Treatment: Evidence of Association in First Episode Psychosis Patients
    Benedicto Crespo-Facorro, Maria Jesús Arranz, Ignacio Mata, Javier Vázquez- Bourgon, Rocío Pérez-Iglesias, Laura Medina-González, José María Pelayo- Terán, Eugenio Carrasco-Marín, José Luis Vázquez-Barquero
  • Staging of Cognitive Impairment, Incidence of Dementia, and Mortality Risk: Preliminary Results with a Simply Method Based on the Mini Mental Status Examination
    Antonio Lobo, Raúl López-Antón, Concepción de-La Cámara, Miguel Ángel Quintanilla, Antonio Campayo, Javier Santabarbara, Tirso Ventura, Andrés Martín, Pedro Saz, and Guillermo Marcos
  • Circadian Rhythms in the Physiopathology of Depression: A New Opportunity of Therapeutic Approach
    Cecilio Álamo and Francisco López-Muñoz

Part II Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry: Agents, Phases and Ages at Expression

  • Adolescent Maturation of Cortical Dopamine
    Patricio O´Donnell
  • Amyloid-b Precursor Protein Induces Glial Differentiation of Neural Progenitor Cells by Activation of the IL-6/gp130 Signaling Pathway
    Young-Don Kwak, Elise Dantuma, Stephanie Merchant, Sergey Bushnev  and Kiminobu Sugaya
  • Stereotypic Progressions in Psychotic Behavior
    Richard M. Kostrzewa, John P. Kostrzewa, Rose Anna Kostrzewa, Florence P. Kostrzewa, Ryszard Brus, Przemyslaw Nowak
  • Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?
    Peter Riederer, Jasmin Bartl, Gerd Laux, Edna Grünblatt
  • Progression of Atrophy in Alzheimer’s disease and Related Disorders
    Jennifer L. Whitwell
  • Neurodevelopment and Learning in Adolescence: Relevance to Staging of psychiatric disorders
    David Sturman and Bita Moghaddam
  • Mild Cognitive Impairment: A 5-Year Follow-Up and Imaging Study
    J.A. Lonie, U.G. Kalu, C.E. Sexton, C.E. Mackay, M. Bastin, E. Terriére, R.E. O’Carroll, K.P. Ebmeier
  • The Neural Circuitry of Autism
    Aysenil Belger, Kimberly L. H. Carpenter, Gunes Yucel, and Katherine M. Cleary

Part III Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders

  • Dopamine System Dysregulation by the Ventral Subiculum as the Common Pathophysiological Basis for Schizophrenia Psychosis, Psychostimulant Abuse, and Stress
    Anthony A. Grace
  • Persistence of Long-Term Memory Storage: New Insights into its Molecular Signatures in the Hippocampus and Related Structures
    Pedro Bekinschtein, Cynthia Katche, Leandro Slipczuk, Carolina Gonzalez, Guido Dorman, Martín Cammarota, Iván Izquierdo, Jorge H. Medina
  • Epigenetically Regulated Imprinted Genes and Foetal Programming
    Eric B. Keverne
  • Regulation of AMPA Receptor Trafficking in the Nucleus Accumbens By Dopamine and Cocaine
    Marina E. Wolf
  • Inhibition of Actin Polymerization Prevents Cocaine-induced Changes in Spine Morphology in the Nucleus Accumbens
    Shigenobu Toda, Haowei Shen, Peter W. Kalivas
  • Decision-Making, Behavioral Supervision and Learning: An Executive Role for the Ventral Premotor Cortex?
    C. Acuña, J.L. Pardo-Vázquez, V. Leborán
  • Antipsychotic Induced Changes in Striatal D2 Receptors in Schizophrenia: in Vivo Evidence from Dopamine Depletion Studies
    Anissa Abi-Dargham, Larry Kegeles, Mark Slifstein and Marc Laruelle
  • The ANKK1 Protein Associated with Addictions has Nuclear and Cytoplasmic Localization and Shows a Differential Response of Ala239Thr to Apomorphine
    E. Garrido, T. Palomo, G. Ponce, I. García-Consuegra, M. A. Jiménez-Arriero, and J. Hoenicka
  • Synaptic and Nuclear Localizations of the G Protein-Coupled Receptor GPR88
    Renaud Massart, Jorge Diaz, and Pierre Sokoloff

Part IV Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

  • Cortical and Sub-Cortical Effects in Primate Models of Cocaine Use: Implications for Addiction and the Increased Risk of Psychiatric Illness
    Charles W. Bradberry
  • Critical Age Windows for Neurodevelopmental Psychiatric Disorders: Evidence from Animal Models
    Eva M. Marco, Simone  Macrí, Giovanni Laviola
  • Immaturities in Incentive Processing and Executive Function in Adolescence
    Charles Geier, Aarthi Padmanabhan, and Beatriz Luna
  • Alpha-Synucleinopathy and Neuropsychological Symptoms in a Population- Based Cohort of the Elderly
    J. Zaccai, C. Brayne, F.E. Matthews, P.G. Ince

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+